Reduction

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

Reservoir of Migraine Therapies Includes Analgesics, AEDs, and now Monoclonal Antibodies

By Davidta Brown, Senior Staff Editor - The pain, nausea, and light or sound sensitivity that comprise a migraine attack…

12 years ago

Drug Shortages: Effects & Costs in the United States Healthcare System

By: Valentina DiGangi,PharmD Candidate c/o 2017, Brandon Hu, PharmD Candidate c/o 2018, Sang Hyo Kim, Staff Editor, Samantha Lau, PharmD…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

Quantifying the Benefits of Pharmacist Prescribing Power

By Davidta Brown, Senior Staff Editor - The idea of granting pharmacists the right to prescribe, as well as to…

12 years ago

Grastek®: FDA Approves New Sublingual Immunotherapy for Allergies

By: Kevin Lin, PharmD Candidate c/o 2015 - This April, the FDA approved three sublingual immunotherapies for pollen induced allergic…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

A Brave New World for Lipid Management

By: Amrita Singh, PharmD Candidate c/o 2015 - Last November, the American College of Cardiology and the American Heart Association…

12 years ago

Long Term PPI Use Heightens Concern of Associated Health Consequences

By: Tamara Yunusova, Senior Staff Editor - Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the…

12 years ago

BRD4 Inhibition Eliminates Malignant Peripheral Nerve Sheath Tumor in Mice

By: Richard Chung, PharmD Candidate c/o 2017 - Malignant peripheral nerve sheath tumor, otherwise known commonly as MPNST, is an…

12 years ago

The Increasing Roles of Pharmacists in Transplant Outcomes

By: Jenny Park, PharmD Candidate c/o 2015 - Medication adherence is a big part of a patient’s success in managing…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Possible Mandatory Lung Cancer Screening

By: Jenny Park, PharmD Candidate c/o 2015 - Lung cancer takes away the lives of about 160,000 individuals annually, which…

13 years ago

The Third Wheel or the Steering Wheel? Pharmacists on the Healthcare Team

By: Joshua Bliss, PharmD Candidate c/o 2016 - Doctor - a word often utilized by both professionals and the general…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Lower Vaccine Costs for Developing Nations

By: Steve Soman, PharmD - India has become a powerhouse in pharmaceutical manufacturing, often supplying generic alternatives at a fraction…

13 years ago

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

Emerging Pathways For Treating Hepatitis C Virus

By:  Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

Ivacaftor (KalydecoTM): Targeting the Core of Cystic Fibrosis

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…

14 years ago

Low-dose SSRIs for the Overly Sensitive Esophagus

By Sunhae Chang, PharmD Candidate c/o 2013 - When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux…

14 years ago

Bisphosphonates and Atypical Fracture Risk

By: Steve Soman, Pharm.D. Candidate c/o 2013 - Bisphosphonates are proven to enhance bone density and reduce fracture incidence in…

14 years ago

The Role of N-Acetylcysteine in Contrast Induced Nephropathy

By: Neal Shah, Co-Editor-In-Chief - Contrast dyes enhance imaging for computer tomography (CT), magnetic resonance (MR), and X-rays.1  Dyes usually…

14 years ago

Understanding Diabetic Ketoacidosis

By: Mohamed Dungersi, Associate Student Editor -  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…

14 years ago

Naloxone Distribution Programs

By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article -…

14 years ago

Role of Calcium Channel Blockers and Beta Blockers in CHF

By: Lunbao Huang Pharm D. Candidate c/o 2013 - The seventh report of the Joint National Committee on high blood…

14 years ago

Sativex®: A Realistic Option for Advanced Cancer Pain?

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 - Nabiximols (Sativex®) is a buccal spray that has been approved for use…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

Liposomal Doxorubicin For Liver Cancer

By Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Over the last two decades, there has been an increasing focus…

14 years ago

FDA Approves Edarbyclor®

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 - Hypertension is a chronic disease that affects one out of every three…

14 years ago

Xigris: A Worldwide Withdrawal

By: Khilna Patel, Pharm.D. Candidate c/o 2012 - On October 25 of this year, Eli Lilly and Company announced a…

14 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago

Faculty Spotlight: Dr. Abu Serajuddin

By: Ebey P. Soman - Dr. Abu Serajuddin is a true inspiration for student pharmacists who wish to enter the…

15 years ago